Progyny (PGNY) Competitors $20.67 -0.22 (-1.07%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. OPCH, GH, RDNT, BTSG, SHC, PRVA, SGRY, CON, VCYT, and LFSTShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Progyny vs. Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Veracyte LifeStance Health Group Option Care Health (NASDAQ:OPCH) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, community ranking, analyst recommendations, media sentiment, profitability, risk and earnings. Which has preferable valuation & earnings, OPCH or PGNY? Option Care Health has higher revenue and earnings than Progyny. Option Care Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.19B1.01$267.09M$1.2425.83Progyny$1.21B1.48$62.04M$0.5736.65 Do analysts recommend OPCH or PGNY? Option Care Health presently has a consensus price target of $35.50, indicating a potential upside of 10.83%. Progyny has a consensus price target of $23.45, indicating a potential upside of 12.28%. Given Progyny's higher possible upside, analysts clearly believe Progyny is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Progyny 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42 Do institutionals and insiders hold more shares of OPCH or PGNY? 98.1% of Option Care Health shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Comparatively, 9.4% of Progyny shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer OPCH or PGNY? In the previous week, Option Care Health had 1 more articles in the media than Progyny. MarketBeat recorded 12 mentions for Option Care Health and 11 mentions for Progyny. Option Care Health's average media sentiment score of 1.89 beat Progyny's score of 1.20 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Progyny 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, OPCH or PGNY? Option Care Health has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500. Comparatively, Progyny has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Is OPCH or PGNY more profitable? Progyny has a net margin of 5.03% compared to Option Care Health's net margin of 4.37%. Option Care Health's return on equity of 15.30% beat Progyny's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.37% 15.30% 6.57% Progyny 5.03%11.36%7.87% Does the MarketBeat Community believe in OPCH or PGNY? Progyny received 38 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 70.34% of users gave Progyny an outperform vote while only 64.00% of users gave Option Care Health an outperform vote. CompanyUnderperformOutperformOption Care HealthOutperform Votes6464.00% Underperform Votes3636.00% ProgynyOutperform Votes10270.34% Underperform Votes4329.66% SummaryOption Care Health and Progyny tied by winning 9 of the 18 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.79B$2.03B$5.33B$8.39BDividend YieldN/A6.96%5.21%4.11%P/E Ratio36.0215.8626.8019.71Price / Sales1.483.54397.78120.67Price / Cash35.589.3238.2534.62Price / Book3.623.926.774.50Net Income$62.04M$87.49M$3.23B$248.22M7 Day Performance-6.32%-4.19%0.48%-0.78%1 Month Performance-6.44%-6.42%9.13%11.53%1 Year Performance-23.06%-28.11%18.58%8.99% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny1.4943 of 5 stars$20.67-1.1%$23.45+13.5%-21.9%$1.77B$1.21B35.55310Positive NewsOPCHOption Care Health4.2133 of 5 stars$33.09-0.4%$35.50+7.3%+10.3%$5.42B$5.19B27.815,600Positive NewsGHGuardant Health4.645 of 5 stars$40.24-1.1%$52.32+30.0%+64.6%$4.99B$774.00M-11.301,790Positive NewsRDNTRadNet3.3694 of 5 stars$60.66-0.8%$69.75+15.0%-2.2%$4.55B$1.87B-866.458,970News CoverageAnalyst DowngradeBTSGBrightSpring Health Services1.6286 of 5 stars$24.11-1.3%$23.56-2.3%+99.7%$4.20B$11.86B-92.7335,000Positive NewsSHCSotera Health2.9359 of 5 stars$12.74-0.5%$15.80+24.0%+9.0%$3.62B$1.11B50.963,000Positive NewsPRVAPrivia Health Group3.5636 of 5 stars$25.00-0.1%$27.38+9.5%+40.5%$3.05B$1.80B250.03810Positive NewsSGRYSurgery Partners2.7906 of 5 stars$23.60-1.4%$34.75+47.2%-10.3%$3.02B$3.17B-49.1712,200Positive NewsCONConcentra Group Holdings ParentN/A$22.54-0.8%$28.50+26.4%N/A$2.87B$1.93B16.8211,000Positive NewsEx-DividendVCYTVeracyte3.9484 of 5 stars$29.00-0.7%$40.90+41.0%+26.7%$2.27B$463.39M-193.33790Positive NewsLFSTLifeStance Health Group2.495 of 5 stars$5.84flat$8.30+42.1%-3.1%$2.27B$1.28B-22.466,640Positive News Related Companies and Tools Related Companies Option Care Health Alternatives Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Privia Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Veracyte Alternatives LifeStance Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.